Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial

Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial

Several vaccines have been developed to control the COVID-19 pandemic. CoronaVac<sup>®</sup>, an inactivated SARS-CoV-2 vaccine, has demonstrated safety and immunogenicity, preventing severe COVID-19 cases. We investigate the safety and non-inferiority of two immunization schedules of Co...

Full description

Bibliographic Details
Main Authors: Katia Abarca, Carolina Iturriaga, Marcela Urzúa, Nicole Le Corre, Augusto Pineda, Carolina Fernández, Angélica Domínguez, Pablo A. González, Susan M. Bueno, Paulina Donato, Pilar Espinoza, Daniela Fuentes, Marcela González, Paula Guzmán, Paula Muñoz-Venturelli, Carlos M. Pérez, Marcela Potin, Álvaro Rojas, José V. González-Aramundiz, Nicolás M. S. Gálvez, Francisca Aguirre-Boza, Sofía Aljaro, Luis Federico Bátiz, Yessica Campisto, Mariela Cepeda, Aarón Cortés, Sofía López, María Loreto Pérez, Andrea Schilling, Alexis M. Kalergis, on behalf of the CoronaVac03CL Study Group
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Vaccines
Subjects:
CoronaVac<sup>®</sup>
phase III clinical trial
SARS-CoV-2
COVID-19
vaccines
immunization schedules
Online Access:https://www.mdpi.com/2076-393X/10/7/1082

Internet

https://www.mdpi.com/2076-393X/10/7/1082

Similar Items